Continuous Glucose Monitoring: Merging Patient Satisfaction with Data-Driven Glycemic Control
CE credit: 1 hour
CE Expiration date: 4/14/2023
Note: ADCES is offering this course to dietitians for 1.0 CPEU. For nursing and pharmacist credit information, please visit the website for Clinical Care Options.
This program is designed to improve learner knowledge and competence in managing glycemic control in patients with diabetes by providing timely treatment intensification according to the guidelines and applying evidence-based treatment strategies for people with diabetes. The certified portion of this program consists of 3 presentations and a podcast.
• Topic 1 – Diabetes Medical Minute: Role and Recommendations for CGM to Improve Outcomes
• Topic 2 – Diabetes Medical Minute: Comparison of Available and Emerging CGM Technology
• Topic 3 – Diabetes Medical Minute: Incorporating CGM Into Practice
• Podcast – Diabetes Medical Minute: Role of the Diabetes Care and Education Specialist in CGM
After you have completed the coursework, you will take the final assessment. It has 9 multiple-choice questions. Your overall course completion will be based upon successfully passing the final assessment with a score of 70% or better. You will get three (3) tries to pass the assessment.
After you successfully complete the final assessment, you will get access to a statement of credit, showing the CE credit you earned. Please print it for your records. (Note, you will be able to return to print it later, if needed.)
For successful completion, participants are required to complete all 3 presentations and the podcast in their entirety, successfully pass the final assessment, and submit the program evaluation at the conclusion of the educational event. Contact email@example.com in the event you choose not to complete the evaluation form.
Learner knowledge and competence will be enhanced in managing glycemic control in people with diabetes by providing timely treatment intensification according to the guidelines and applying evidence-based treatment strategies for people with diabetes.
• Explain the role of CGM in reducing postprandial hyperglycemia, increasing time in range, improving A1C, and reducing diabetes stress.
• Compare and contrast available and emerging CGM devices.
• Employ a stepped approach to reviewing and interpreting CGM data in order to develop a personalized management plan with patients.
• Collaborate with the diabetes healthcare team (i.e., specialist, primary care clinician, diabetes educator) to improve adoption of CGM devices in practice.
Vivian A. Fonseca, MD, FRCP
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, LA
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE
Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Pamela Kushner, MD, FAAFP
University of California Irvine Medical Center
Los Alamitos, CA
For nursing and pharmacist credit information, please visit the website for Clinical Care Options:
The Association of Diabetes Care & Education Specialists (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education unit (CPEU) for completion of this activities/materials. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.
Certified Diabetes Educators: To satisfy the requirements for renewal of certification for the National Certification Board of Diabetes Educators (NCBDE), continuing education activities must be diabetes related and approved by a provider on the NCBDE list of Approved Providers (www.ncbde.org). NCBDE does not approve continuing education. The Association of Diabetes Care & Education Specialists (ADCES) is on the NCBDE list of Approved Providers.
Board Certified Advanced Diabetes Management (BC-ADM)
ADCES is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.
It is the policy of the Association of Diabetes Care & Education Specialists to require that anyone who has an opportunity to affect continuing education activity content (e.g. authors, presenters, and program planners) with products or services from a commercial interest with which s/he has financial relationship/s with commercial entities to participants. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof) among education activity planners and faculty are as follows:
The program is supported by an educational grant from Lilly.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE, has disclosed that she has received consulting fees from Dexcom, Novo, and LifeScan.
Vivian A. Fonseca, MD, FRCP, has disclosed that he has received funds for research support (paid to his institution) from Bayer and Boehringer Ingelheim; has received consulting fees from Abbott, Asahi Kasei, AstraZeneca, Intarcia, Lilly, Novo Nordisk, Sanofi, and Takeda; and owns stock or stock options in Amgen, BRAVO4Health, Insulin Algorithms, and Microbiome Technologies.
Pamela Kushner, MD, FAAFP, has disclosed that she has received consulting fees from AstraZeneca, Janssen, Lilly, and Novo Nordisk and fees for non-CME/CE services from AstraZeneca, Janssen, and Novo Nordisk.
Jodi Lavin-Tompkins MSN, RN, CDE, BC-ADM – No conflicts of interest
Clinical Care Options Staff
Zachary Schwartz, MSc, has no relevant conflicts of interest to report.
Manager, Editorial Operations
Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Senior Clinical Editor
Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Sharon Hwang, MD MPH, has no relevant conflicts of interest to disclose.
Associate Director, Scientific Services
Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.
Disclosure of Relevant Financial Relationships and Mechanism to Identify and Resolved Conflicts of Interest
Undertaking review of the educational activity by a content reviewer to evaluate for potential bias, balance in presentation, evidence-based content or other indicators of integrity, and absence of bias, AND monitoring the educational activity to evaluate for commercial bias in the presentation, AND reviewing participant feedback to evaluate for commercial bias in the activity.